title: Statins cause profound effects on gene expression in human cancer cells in vitro: the role of membrane microdomains.
abstract: There is increasing evidence that statin treatment can be beneficial in certain cancer patients. To determine if these benefits are a direct result of the cholesterol-lowering effects of statins or a result of secondary, protein transcription effects, the impacts of pravastatin and a cholesterol sequestrating agent methyl-beta-cyclodextrin (MbetaCD) on mRNA expression in the breast cancer cell MDA-MB-231 and the lung carcinoma cell Calu-1 have been compared by microarray techniques. The effects of these agents on cholesterol-rich rafts and caveolae, which have significance in cancer signaling, have also been examined. Both treatments caused a general downregulation of not only signal transduction including cancer pathway proteins, but also apoptosis and chemokine pathways, with statins impacting 35 genes by twofold or greater in MDA-MB-231 and > 300 genes in Calu-1. These manifold dysregulations could also explain the various side effects reportedly caused by statins. MbetaCD produced far fewer statistical events than pravastatin in the breast cancer line but many more in the lung cell line. Pravastatin increased expression of CAV1 but caveolae density decreased and overall raft density was unaffected. MbetaCD also caused an increase in CAV1 expression and reduced the prevalence of both rafts and caveolae. It is proposed that sequestration of cholesterol from the membrane by MbetaCD is not equivalent to blockade of the cholesterol pathway and causes different effects on microdomain-mediated signal transduction dependant on the cell line. The profound effects of statins on mRNA expression can be explained by the failure of caveolin-1 to properly complex with cholesterol in an altered sterol environment, with caveolae acting as the main loci for signaling directed towards those transcription processes unaffected by MbetaCD. Targeted inhibition of the postmevalonate pathway could offer an opportunity to specifically reduce caveolae-based signaling in cancer cells. The observed impact of pravastatin on gene expression may explain the pleiotropic effects of statins when they are used as adjuvants in chemotherapy and suggests impact on gene expression as a possible cause of side effects from statin use.
authors.affiliation: Structural Biology Research Group, Institute of Science Technology in Medicine, Keele University, Keele, Staffordshire, UK. d.garnett@istm.keele.ac.uk
authors.forename: David John
authors.initials: DJ
authors.lastname: Garnett
authors.forename: Trevor James
authors.initials: TJ
authors.lastname: Greenhough
mesh_terms: D045744:Cell Line, Tumor; D005455:Fluorescent Antibody Technique; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D066298:In Vitro Techniques; D021962:Membrane Microdomains; D009369:Neoplasms / Q000235:genetics*; D017035:Pravastatin / Q000494:pharmacology*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D017035:Pravastatin
references.citation: Vascul Pharmacol. 2009 Oct;51(4):253-61
references.pmid: 19586617
references.citation: Brain Res Brain Res Rev. 2005 Apr;48(2):240-50
references.pmid: 15850663
references.citation: Gynecol Oncol. 2008 Oct;111(1):102-5
references.pmid: 20698078
references.citation: Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1363-70
references.pmid: 16029794
references.citation: Cytokine. 2011 Apr;54(1):100-7
references.pmid: 21292498
references.citation: Int J Cardiol. 2007 Jan 2;114(1):71-7
references.pmid: 16678288
references.citation: Exp Cell Res. 2004 Dec 10;301(2):305-19
references.pmid: 15530865
references.citation: Cell Signal. 2010 May;22(5):749-58
references.pmid: 20060890
references.citation: Atherosclerosis. 2011 Nov;219(1):253-8
references.pmid: 21855068
references.citation: Mol Immunol. 2006 Mar;43(7):891-6
references.pmid: 16054696
references.citation: Eur J Intern Med. 2009 Dec;20(8):e159
references.pmid: 19892297
references.citation: Clin Cancer Res. 1996 Mar;2(3):483-91
references.pmid: 9816194
references.citation: Mol Biol Cell. 1999 Apr;10(4):961-74
references.pmid: 10198050
references.citation: JAMA. 2003 Apr 2;289(13):1681-90
references.pmid: 12672737
references.citation: Med Hypotheses. 2006;66(6):1199-204
references.pmid: 16413682
references.citation: J Biol Chem. 2009 Apr 3;284(14):9426-32
references.pmid: 19158077
references.citation: JAMA. 2006 Jan 4;295(1):74-80
references.pmid: 16391219
references.citation: Am J Cardiol. 2003 Aug 1;92(3):305-8
references.pmid: 12888140
references.citation: Lung Cancer. 2012 Mar;75(3):275-9
references.pmid: 21958449
references.citation: Med Hypotheses. 2006;66(3):609-11
references.pmid: 16171951
references.citation: J Clin Oncol. 2010 Jun 1;28(16):2653-9
references.pmid: 20421534
references.citation: Cancer Lett. 2008 Sep 18;268(2):187-201
references.pmid: 18482795
references.citation: Oncogene. 2007 Feb 22;26(8):1110-21
references.pmid: 17146433
references.citation: Cancer Lett. 2007 Jun 8;250(2):220-8
references.pmid: 17125918
references.citation: Am J Pathol. 2010 Jul;177(1):291-9
references.pmid: 20489141
references.citation: Biochem J. 2000 Mar 15;346 Pt 3:603-10
references.pmid: 10698685
references.citation: Eur J Cardiovasc Nurs. 2012 Mar;11(1):85-96
references.pmid: 20875773
references.citation: Curr Opin Lipidol. 2000 Jun;11(3):253-60
references.pmid: 10882340
references.citation: Arterioscler Thromb Vasc Biol. 1998 Nov;18(11):1671-8
references.pmid: 9812903
references.citation: Am J Cardiol. 2007 Mar 1;99(5):732-8
references.pmid: 17317382
references.citation: Med Hypotheses. 2010 Mar;74(3):613-4
references.pmid: 19896281
references.citation: Eur J Vasc Endovasc Surg. 2011 Dec;42(6):722-30
references.pmid: 21741279
references.citation: Nature. 2002 Dec 19-26;420(6917):868-74
references.pmid: 12490960
references.citation: Int J Cardiol. 2006 Apr 28;109(1):7-15
references.pmid: 16054715
references.citation: CMAJ. 2009 Jul 7;181(1-2):E11-8
references.pmid: 19581603
references.citation: J Urol. 2011 Apr;185(4):1268-73
references.pmid: 21334020
references.citation: Eur J Cancer. 2008 Oct;44(15):2122-32
references.pmid: 18707867
references.citation: Endocrinology. 1992 Jan;130(1):43-52
references.pmid: 1727716